Perdomo, I.; Mora, C.; Pinillos, J.; Oñate-Garzón, J.; Salamanca, C.H.
Development, Characterization, and Antimicrobial Evaluation of Hybrid Nanoparticles (HNPs) Based on Phospholipids, Cholesterol, Colistin, and Chitosan Against Multidrug-Resistant Gram-Negative Bacteria. Pharmaceutics 2025, 17, 182.
https://doi.org/10.3390/pharmaceutics17020182
AMA Style
Perdomo I, Mora C, Pinillos J, Oñate-Garzón J, Salamanca CH.
Development, Characterization, and Antimicrobial Evaluation of Hybrid Nanoparticles (HNPs) Based on Phospholipids, Cholesterol, Colistin, and Chitosan Against Multidrug-Resistant Gram-Negative Bacteria. Pharmaceutics. 2025; 17(2):182.
https://doi.org/10.3390/pharmaceutics17020182
Chicago/Turabian Style
Perdomo, Isabella, Carolina Mora, Juan Pinillos, José Oñate-Garzón, and Constain H. Salamanca.
2025. "Development, Characterization, and Antimicrobial Evaluation of Hybrid Nanoparticles (HNPs) Based on Phospholipids, Cholesterol, Colistin, and Chitosan Against Multidrug-Resistant Gram-Negative Bacteria" Pharmaceutics 17, no. 2: 182.
https://doi.org/10.3390/pharmaceutics17020182
APA Style
Perdomo, I., Mora, C., Pinillos, J., Oñate-Garzón, J., & Salamanca, C. H.
(2025). Development, Characterization, and Antimicrobial Evaluation of Hybrid Nanoparticles (HNPs) Based on Phospholipids, Cholesterol, Colistin, and Chitosan Against Multidrug-Resistant Gram-Negative Bacteria. Pharmaceutics, 17(2), 182.
https://doi.org/10.3390/pharmaceutics17020182
